A study suggests zinc holds promise for addressing recurrent thrush, a condition affecting 138 million women worldwide. Current treatments often fail to prevent its recurrence. Lead researcher Dr. Duncan Wilson of the University of Exeter’s MRC Centre for Medical Mycology highlights zinc’s potential in blocking inflammatory responses triggered by the Pra1 molecule associated with thrush. Initial findings showed zinc sulphate in Juviagel prevented reinfection in five out of six women. Fempharma conducts clinical trials to confirm Juviagel’s effectiveness in preventing vaginal yeast infections. This research underscores the importance of basic research in uncovering new treatment pathways and potentially improving women’s health globally.
Home » Zinc’s Potential in Addressing Recurrent Thrush: A Promising Avenue for Women’s Health